Cellectar Biosciences Inc (NAS:CLRB) Stock News, Headlines & Updates
Cellectar Biosciences Inc Stock News from GuruFocus
- 1
- 2
Jul 03, 2025
Insider Buying: James Caruso Acquires 10,000 Shares of Cellectar Biosciences Inc (CLRB)
GuruFocus News • 9:00am
Jul 02, 2025
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
Marketwired • 4:00pm
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option | CLRB Stock News
GuruFocus News • 3:34pm
Jul 01, 2025
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
Marketwired • 9:00am
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering | CLRB Stock News
GuruFocus News • 8:45am
Jun 26, 2025
CLRB: New Management by Ladenburg Thalmann | CLRB Stock News
GuruFocus News • 8:48am
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
Marketwired • 8:00am
Cellectar Biosciences (CLRB) Secures Multi-Year Isotope Supply Agreement with Nusano | CLRB Stock News
GuruFocus News • 7:30am
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement | CLRB Stock News
GuruFocus News • 7:16am
Jun 24, 2025
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
Marketwired • 8:00am
Cellectar Biosciences (CLRB) Submits Study Protocol to FDA for Promising Cancer Treatment | CLRB Stock News
GuruFocus News • 7:49am
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC) | CLRB Stock News
GuruFocus News • 7:48am
Cellectar Biosciences (CLRB) Trading Halted Pending News | CLRB Stock News
GuruFocus News • 7:15pm
Jun 18, 2025
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
Marketwired • 4:00pm
Cellectar Biosciences (CLRB) Announces One-for-Thirty Reverse Stock Split
GuruFocus News • 3:58pm
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split | CLRB Stock News
GuruFocus News • 3:48pm
Cellectar Biosciences (CLRB) Announces Reverse Stock Split | CLRB Stock News
GuruFocus News • 3:46pm
Jun 11, 2025
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
Marketwired • 8:00am
Cellectar Biosciences (CLRB) Reports Promising Phase 1 Trial Results for Iopofosine I 131 | CLRB Stock News
GuruFocus News • 7:32am
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma | CLRB Stock News
GuruFocus News • 7:16am
Jun 05, 2025
Cellectar Biosciences (CLRB) Secures $2.5 Million from Stock Sale
GuruFocus News • 8:58am
Cellectar Biosciences (CLRB) Secures $2.5M Through Stock Sale Agreements | CLRB Stock News
GuruFocus News • 8:30am
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules | CLRB Stock News
GuruFocus News • 8:21am
Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
Marketwired • 8:00am
Jun 04, 2025
Cellectar Biosciences (CLRB) Secures Breakthrough Therapy Designation | CLRB Stock News
GuruFocus News • 11:30am
Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)
Marketwired • 8:00am
Cellectar Biosciences (CLRB) Gains FDA Breakthrough Therapy Designation for Iopofosine I 131 | CLRB Stock News
GuruFocus News • 7:33am
Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM) | CLRB Stock News
GuruFocus News • 7:16am
May 14, 2025
Cellectar Biosciences (CLRB) Downgraded to 'Hold' by Maxim Group | CLRB Stock News
GuruFocus News • 1:01pm
Cellectar Biosciences (CLRB) Downgraded Amid Strategic Uncertainty | CLRB Stock News
GuruFocus News • 7:30am
Cellectar Biosciences Inc (CLRB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus News • 1:07am
Q1 2025 Cellectar Biosciences Inc Earnings Call Transcript
GuruFocus News • 11:07pm
May 13, 2025
Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Marketwired • 7:00am
CLRB Focuses on Advancing Radiotherapeutic Developments Amidst Regulatory Plans | CLRB Stock News
GuruFocus News • 6:49am
CLRB Financial Update: Cash Reserves Decline as of March 2025 | CLRB Stock News
GuruFocus News • 6:31am
Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update | CLRB Stock News
GuruFocus News • 6:16am
May 07, 2025
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025
Marketwired • 8:00am
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025 | CLRB Stock News
GuruFocus News • 7:18am
Apr 30, 2025
Cellectar Announces Plan to Explore Strategic Alternatives
Marketwired • 8:00am
Cellectar Biosciences (CLRB) Considers Strategic Options to Enhance Value | CLRB Stock News
GuruFocus News • 7:47am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news